Aaron Wealth Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$775K Sell
32,183
-3,097
-9% -$81K 0.04% 309
2026
Q1
$991K Buy
35,280
+6,225
+21% +$166K 0.06% 227
2025
Q4
$723K Sell
29,055
-11,389
-28% -$287K 0.04% 336
2025
Q3
$1.03M Buy
40,444
+21,152
+110% +$522K 0.06% 227
2025
Q2
$468K Buy
19,292
+1,873
+11% +$43.7K 0.05% 253
2025
Q1
$441K Sell
17,419
-2,226
-11% -$58.2K 0.05% 246
2024
Q4
$521K Buy
19,645
+3,069
+19% +$83.2K 0.06% 191
2024
Q3
$480K Buy
16,576
+4,878
+42% +$142K 0.06% 198
2024
Q2
$327K Buy
11,698
+3,411
+41% +$93.9K 0.05% 218
2024
Q1
$230K Buy
8,287
+1,218
+17% +$33.8K 0.03% 268
2023
Q4
$204K Sell
7,069
-20,586
-74% -$622K 0.03% 249
2023
Q3
$917K Buy
27,655
+13,046
+89% +$461K 0.12% 91
2023
Q2
$536K Buy
14,609
+2,372
+19% +$92.3K 0.07% 150
2023
Q1
$499K Buy
12,237
+3,175
+35% +$137K 0.07% 153
2022
Q4
$464K Buy
9,062
+3,156
+53% +$151K 0.07% 159
2022
Q3
$258K Buy
5,906
+605
+11% +$29.4K 0.05% 174
2022
Q2
$277K Buy
5,301
+2,111
+66% +$108K 0.07% 157
2022
Q1
$165K Buy
+3,190
New +$166K 0.04% 211

Other funds holding PFE

Aaron Wealth Advisors's PFE Position: Q2 2026 in Review

Aaron Wealth Advisors reduced its Pfizer (PFE) stake by 8.8% in Q2 2026, selling an estimated $81K and leaving 32,183 shares worth $775K. The position accounts for 0.04% of the portfolio, ranked #309.

Aaron Wealth Advisors first reported a position in PFE in Q1 2022 and has held it in 18 quarters since. The position peaked at $1.03M in Q3 2025. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Aaron Wealth Advisors held 32,183 shares of Pfizer worth $775K as of Q2 2026.
  • Aaron Wealth Advisors sold 3,097 Pfizer shares in Q2 2026, an estimated $81K.
  • Pfizer made up 0.04% of Aaron Wealth Advisors's portfolio in Q2 2026, its #309 holding.
  • Aaron Wealth Advisors first reported a position in Pfizer in Q1 2022 and has held it in 18 quarters since.
  • Aaron Wealth Advisors's Pfizer position peaked at $1.03M in Q3 2025.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Aaron Wealth Advisors's 13F filing for Q2 2026, filed 16 Jul 2026.